Clinical trials sponsored by Keymed Biosciences Co.Ltd

Phase breakdown

Conditions studied

Recruiting trials led by Keymed Biosciences Co.Ltd

• A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
  NCT07230483 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
  NCT06619613 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location
• Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
  NCT07011524 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
  NCT06947980 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Keymed Biosciences Co.Ltd recruiting for?

Keymed Biosciences Co.Ltd is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.